BeStock  
Stocks › Biotechnology › PHAT

Phathom Pharmaceuticals PHAT

US equityMarket cap rank #3686Biotechnology
$4.66 −$0.42 (-8.27%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $4.66 0.00%
Open$4.93
Prev close$5.08
Day range$4.62 – $5.15
Volume1.33M
Market cap$378.82M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts6
Average target$16.90+262.7% vs. price
  • Buy 83%
  • Hold 17%
Low $7.50Now $4.66Avg $16.90High $26.00

Recent rating changes

The last 20 actions on file set price targets from $7.50 to $28.00, averaging $20.74.

DateFirmRatingTarget
2 Nov 2026 Leerink Partners HOLD $7.50
30 Oct 2026 H.C. Wainwright BUY $26.00
30 Oct 2026 Barclays BUY $14.00
29 Oct 2026 Guggenheim BUY $22.00
23 Oct 2026 Cantor Fitzgerald BUY –
21 Oct 2026 Craig-Hallum BUY $15.00
21 Sep 2026 H.C. Wainwright BUY $26.00
9 Sep 2026 Leerink Partners HOLD $10.00
17 Aug 2026 Barclays BUY $14.00
31 Jul 2026 Craig-Hallum BUY $20.00
31 Jul 2026 Raymond James BUY $21.00
31 Jul 2026 Guggenheim BUY $22.00
31 Jul 2026 H.C. Wainwright BUY $26.00
30 Jul 2026 Needham BUY $22.00
21 Jul 2026 Needham BUY $28.00
21 Jul 2026 Guggenheim BUY $25.00
13 Jul 2026 Craig-Hallum BUY –
23 Jun 2026 Craig-Hallum BUY –
17 Jun 2026 H.C. Wainwright BUY $26.00
1 Jun 2026 Needham BUY $28.00

Discussion

No comments yet — be the first to weigh in on PHAT.

Sign in to join the discussion.

Scroll to Top